Senseonics Holdings, Inc. key statistics and ratios
In fiscal 2025, Senseonics Holdings, Inc. had an operating margin of -193.8%, debt equal to 65.0% of equity and a current ratio of 4.83. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 100.0% | −98.8% | −53.1% | −43.1% | −91.3% | — | −5.9% | 16.6% | 13.8% | 2.4% | 44.7% | 54.9% |
| Operating margin | <−999% | <−999% | −883.6% | −463.1% | −613.4% | <−999% | −418.1% | −418.7% | −337.7% | −333.0% | −193.8% | −223.2% |
| Net margin | <−999% | <−999% | −927.4% | −497.0% | −542.2% | <−999% | <−999% | 867.0% | −269.8% | −349.8% | −196.0% | −225.3% |
| Free-cash-flow margin | <−999% | <−999% | −880.0% | −485.2% | −643.6% | <−999% | −411.6% | −406.5% | −314.9% | −279.0% | −170.9% | −199.5% |
| Return on equity | — | — | — | — | — | — | — | — | — | — | — | −144.5% |
| Return on assets | −550.9% | −317.3% | −173.3% | −91.3% | −78.9% | −207.6% | −257.6% | 75.5% | −38.2% | −65.9% | −61.0% | −72.2% |
| Asset turnover | 0.01 | 0.02 | 0.19 | 0.18 | 0.15 | 0.06 | 0.12 | 0.09 | 0.14 | 0.19 | 0.31 | 0.32 |
| Current ratio | 0.68 | 1.84 | 1.94 | 5.47 | 1.01 | 1.82 | 7.85 | 5.12 | 7.53 | 2.35 | 4.83 | 6.74 |
| Debt to equity | — | — | 336.0% | 95.0% | — | — | — | — | 131.7% | — | 65.0% | 67.5% |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m |
| R&D as % of revenue | >999% | >999% | 482.3% | 168.5% | 180.4% | 412.5% | 199.0% | 242.4% | 217.7% | 183.1% | 89.6% | 75.9% |
| SG&A as % of revenue | — | — | — | — | — | 835.5% | 213.2% | 193.0% | 133.7% | 152.3% | 148.9% | 202.2% |
| Capital spending as % of revenue | 531.6% | 144.3% | 5.4% | 5.2% | 4.9% | 3.7% | 1.5% | 1.9% | 1.6% | 10.0% | 3.2% | 1.8% |
| Free cash flow ÷ net income | — | — | — | — | — | — | — | −46.9% | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | −95.0% | 47.6% | 24.1% | 46.9% | 42.8% | 53.8% | 59.3% | 59.1% |
| Operating margin | −535.9% | −172.0% | −215.6% | −215.4% | −242.1% | −146.8% | −271.9% | −248.5% |
| Net margin | −562.4% | −186.3% | −227.9% | −218.1% | −241.3% | −146.0% | −276.1% | −253.4% |
| Free-cash-flow margin | −342.8% | −172.1% | −263.9% | −141.2% | −197.4% | −128.8% | −274.4% | −209.6% |
| Current ratio | 2.47 | 2.35 | 6.88 | 9.58 | 6.23 | 4.83 | 3.51 | 6.74 |
| Debt to equity | — | — | 99.3% | 37.2% | 45.1% | 58.3% | 104.6% | 61.8% |
| R&D as % of revenue | 247.4% | 112.8% | 116.7% | 116.0% | 95.8% | 61.9% | 73.5% | 80.4% |
| SG&A as % of revenue | 193.5% | 106.8% | 123.0% | 146.3% | 189.1% | 138.7% | 257.7% | 227.2% |
Financial health
- Short-term assets cover short-term liabilities $166m of assets due within a year against $25m of liabilities due within a year.
- Short-term assets cover long-term liabilities $166m short-term assets against $62m of longer-dated liabilities.
- More cash than debt $45m of cash against $56m of debt.
- Debt below 40% of shareholders' equity Debt is 62% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt −$96m of operating cash flow against $56m of debt.
- Operating profit covers interest at least five times over Operating income of −$108m against $5m of interest.
Moat
Weak moat
How hard Senseonics Holdings's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 0 / 20
Net income has been a median -67.0% of total assets over 10 years.
- Pricing power 0 / 20
Gross margin has been a median 4.6%, moving by 81.2 percentage points (standard deviation) across 10 years.
- Durability 10 / 20
Operating margin has been a median -458.0%; its worst year was -2618.6%.
- Cash conversion 0 / 20
Free cash flow was positive in 0 of 10 years, at a median -461.3% of revenue.
- Discipline 0 / 20
The diluted share count rose 370.2% over five years; stock-based pay has been a median 42.9% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Iridex Corp statistics
- Clearpoint Neuro, Inc. statistics
- Koru Medical Systems, Inc. statistics
- Trisalus Life Sciences, Inc. statistics
- Sanuwave Health, Inc. statistics
Head to head: IRIX vs SENSCLPT vs SENSKRMD vs SENS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies